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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2005.07.039Objectives: Near-infrared spectroscopy monitors cerebral oxygen saturation. This
parameter parallels jugular venous oxygen saturation and reflects the balance
between cerebral oxygen supply and demand. Experience with near-infrared spec-
troscopy in univentricular physiology is limited. This study explores the relationship
between cerebral oxygen saturation, jugular venous oxygen saturation, and other
variables of cerebral perfusion in a model of univentricular physiology.
Methods: Univentricular physiology was created in newborn piglets by means of an
aortopulmonary shunt, echocardiography-guided atrial septostomy, tricuspid valve
avulsion, and pulmonary artery occlusion. Intra-aortic balloon inflation was used to
increase afterload. Cerebral oxygen saturation monitoring (INVOS 5100; Somanet-
ics Corp, Troy, Mich), physiologic recordings, and stable-isotope microsphere
determination of cerebral blood flow were performed at baseline and after conver-
sion to univentricular physiology (30 minutes, 120 minutes, and during afterload
augmentation).
Results: Univentricular physiology resulted in lower cerebral oxygen saturation,
arterial oxygen content, jugular venous oxygen saturation, and cerebral oxygen
delivery. Afterload augmentation increased cerebral oxygen saturation, arterial
oxygen content, and jugular venous oxygen saturation, whereas cerebral oxygen
delivery was unaffected because of lower cerebral blood flow. Cerebral oxygen
saturation predicted jugular venous oxygen saturation, arterial oxygen saturation,
and arterial oxygen content. No association was found with cerebral oxygen deliv-
ery, which decreased in parallel with cerebral oxygen saturation when the single-
ventricle physiology model was established but failed to increase during afterload
augmentation.
Conclusions: This study shows that in univentricular physiology cerebral oxygen
saturation correlates well with jugular venous oxygen saturation, arterial oxygen
saturation, and arterial oxygen content. However, our findings suggest that in
singe-ventricle physiology changes in cerebral oxygen saturation need to be inter-
preted in the context of changes in arterial oxygenation.
Transcranial near-infrared spectroscopy (NIRS) is a novel technology usedclinically to monitor regional cerebral O2 saturation (rSO2).1 It allows thenoninvasive detection of changes in the ratio of oxyhemoglobin to deoxy-
hemoglobin (rSO2 index) in the frontal cortex, thus providing indirect information
on the adequacy of cerebral oxygenation.2
Previous experience with NIRS in clinical practice has focused primarily on the
detection of cerebral hypoxia in the context of normoxia and biventricular physi-
ology.3,4 In this setting rSO2 has been shown to parallel jugular venous O2saturation
(jvSO2) consistently.5 RSO2 monitoring has been found to be useful in a variety of
clinical settings, especially cardiac and vascular surgery, as a surrogate indicator of
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as a trend monitor, a decrease in rSO2 can reflect a shift in
the balance between cerebral oxygen supply and demand
and therefore suggests cerebral hypoxia.
Few studies on the use of NIRS in children with con-
genital heart disease have been reported,8-10 and the expe-
rience with this technology in cyanotic children with single-
ventricle physiology (SVP) is limited.11 In contrast to
biventricular physiology, rapid changes in systemic and
pulmonary vascular resistance can produce changes in ce-
rebral perfusion in SVP, as well as significant fluctuations in
pulmonary blood flow and therefore arterial oxygenation.
Previous reports have indicated that NIRS is heavily influ-
enced by markers of arterial oxygenation, such as arterial O2
content (CaO2) and arterial O2 saturation.12 We hypothe-
sized that changes in arterial oxygenation occurring simul-
taneously with changes in cerebral blood flow (CBF) could
influence the ability of transcranial NIRS to predict changes
in cerebral oxygenation. In our study we investigated the
relationship between rSO2, as measured with a commer-
cially available NIRS device, and jvSO2 in an animal model
of hypoxemia and SVP. We also explored the association
between rSO2, cerebral O2 delivery, and other physiologic
variables of cerebral oxygenation in an environment in
which simultaneous changes in CaO2 and CBF were in-
duced by afterload augmentation.
Methods
Animals
Eight Yorkshire newborn piglets (3.7  0.5 kg) were used. The
study was approved by the Animal Care and Use Committee of the
University of Miami Miller School of Medicine and carried out in
compliance with the 1996 National Research Council guidelines
on the Care and Use of Laboratory Animals.
Surgical Preparation
Piglets were anesthetized with intramuscular ketamine (40 mg/kg)
and xylaxine (4 mg/kg), intubated through a tracheostomy, and
started on volume-control ventilation (tidal volume, 25-30 mL/kg;
rate, 25 breaths/min; inspired O2 fraction, 0.25). Anesthesia was
maintained with continuous infusion of fentanyl (50
g · kg1 · h1), pancuronium (0.4 g · kg1 · h1), and midazo-
lam (0.2 mg · kg1 · h1). A catheter was inserted in the femoral
Abbreviations and Acronyms
CaO2  arterial oxygen content
CBF  cerebral blood flow
dpm  disintegrations per minute
jvSO2 jugular venous oxygen saturation
NIRS near-infrared spectroscopy
rSO2  cerebral oxygen saturation
SVP  single-ventricle physiologyartery for pressure monitoring and blood sampling. A 6F intro-
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augmentation) was inserted in the opposite femoral artery. A 7F
introducer sheath was placed in the femoral vein for fluid admin-
istration and subsequent insertion of an atrial septostomy catheter.
A catheter was inserted in the left internal jugular vein for venous
blood sampling. Electrocardiography, rectal temperature, and rSO2
were monitored.
The single-ventricle model resembled that described by oth-
ers.13,14 Through a median sternotomy, catheters were placed in
the right and left atrium. Heparin was administered (150 U/kg),
and a 3.5-mm polytetrafluoroethylene* shunt was interposed be-
tween the aorta (proximal to the take-off of the innominate artery)
and the pulmonary artery. While the shunt was clamped, a 2-mL
balloon septostomy catheter (Medtronic Vascular, Danvers, Mass)
was advanced from the right femoral vein into the right atrium.
Epicardial 2-dimensional echocardiography was used to direct the
catheter across the atrial septum and perform a pull-back septos-
tomy. The same catheter was then advanced into the right ventri-
cle. The tricuspid valve was made incompetent by repeatedly
withdrawing the inflated balloon across the valve. Finally, the
shunt was opened, and the main pulmonary artery was occluded.
This allowed the left ventricle to support both the systemic and
pulmonary circulations, reproducing a physiology similar to that of
pulmonary atresia with intact ventricular septum.
Experimental Protocol
Eight piglets were included in the study group. Animals were
ventilated at a constant fraction of inspired oxygen of 25%, ad-
justing the respiratory rate to maintain a PCO2 of between 35 and
45 mm Hg. Rectal temperature was kept at 35.5°C to 36.5°C. On
the basis of experience from previous pilot experiments, normal
saline (4 mL · kg1 · h1), dopamine (5-10 g · kg1 · min1),
and epinephrine (0.05-0.1 g · kg1 · min1) were administered in
all animals throughout the entire experiment to maintain cardio-
vascular stability and avoid hemodynamic perturbations. Calcium
gluconate and sodium bicarbonate were given as needed. Fresh
whole blood was obtained from an adult pig and infused to
maintain a hemoglobin concentration as close to baseline as
possible.
Data collection was carried out at baseline and after conversion
to SVP (30 minutes, 120 minutes, and during afterload augmen-
tation). Measurements during afterload augmentation were ob-
tained 15 minutes after inflating a balloon in the distal descending
thoracic aorta. Data collected included hemodynamic parameters,
blood sampling (arterial, central venous, and cerebral venous,
hemoglobin, and lactate), determination of total cardiac output
with an electromagnetic flowmeter, determination of CBF with
stable-isotope microsphere injections, and transcranial measure-
ment of rSO2 by using NIRS. At completion, piglets were killed
with KCl and fentanyl. An autopsy was performed to confirm the
correct positioning of all indwelling catheters and the adequacy of
the atrial septostomy and that of the aortopulmonary shunt anas-
tomoses. The brain was removed and weighed for blood flow
determinations.*Gore-Tex shunt, registered trademark of W.L. Gore & Associates, Inc, New-
ark, Del.
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Stable-isotope microspheres (15  5 m; BioPhysics Assay Lab-
oratory, Inc, Worcester, Mass) were used as described by others.15
Microspheres labeled with nonradioactive isotopes were adminis-
tered over 3 seconds through the left atrial catheter, and reference
samples were collected over 90 seconds from the femoral artery (2
mL/min). A total of 1  106 microspheres was injected in the
biventricular state, whereas 2.5  106 were injected in SVP.
Experience with microspheres in a univentricular model is lacking
in the literature. On the basis of our previous experiments, we
demonstrated that 2.5  106 microspheres in the univentricular
state compensated for run-off through the pulmonary circulation
and ensured adequate microsphere concentration in the brain. At
the end of the experiment, tissue samples were obtained from
different brain regions (cortex, white matter, thalamus, hippocam-
pus, brainstem, and cerebellum), weighed fresh, and dried in a
warming oven at 60°C for 48 hours. Dried samples were sent for
analysis and processed by using neutron activation.15 This tech-
nique entails exposure of the isotope to a neutron beam, which
results in an activated radioactive nucleus. Activated labels are
then allowed to decay for 48 hours, during which gamma rays are
emitted and measured. The signal is proportional to the concen-
tration of the isotope in the sample. Results of the assay for each
label are reported in disintegrations per minute (dpm). CBF is
expressed in milliliters per minute per 100 grams and calculated by
normalizing the concentration of microspheres in the tissue sample
(dpm per gram) to the concentration in the reference sample (dpm
per minute per milliliter). Total CBF was calculated by averaging
all measurements obtained from both hemispheres.
Determination of rSO2
A commercially available device (INVOS 5100 Cerebral
Oxymeter; Somanetics Corp, Troy, Mich) was used to measure the
tissue oxygen saturation index (rSO2 index) in the frontal cerebral
cortex.5,8 This technology entails the use of near-infrared light
(730-nm and 810-nm wavelength) to measure the absorption spec-
tra of oxyhemoglobin and deoxyhemoglobin. After shaving the
scalp, a 30-mm patch containing the NIRS-emitting source and
sensor was placed on the forehead and connected to the infrared
spectrophotometer unit. The NIRS probe measures the rSO2 index
in a banana-shaped volume of tissue of 1.5 cm3 in depth, subtract-
ing superficial light-scattering signals that originate from extracra-
nial tissues. The device monitor displays data continuously, al-
though for the statistical analysis, we used NIRS data collected at
steady state at selected data points simultaneously with arterial and
jugular venous blood gases.
Physiologic Measurements and Calculations
Total cardiac output (excluding coronary blood flow) was deter-
mined by using an electromagnetic flowmeter (Transonic Systems,
Inc, Ithaca, NY) placed on the ascending aorta. After conversion to
SVP, pulmonary blood flow was determined by placing the flow-
meter on the pulmonary artery distal to the aortopulmonary shunt,
as described by others.13,14
Total left ventricular outflow indexed by body weight was
calculated as left ventricular output (in milliliters) per minute
divided by body weight (in kilograms). The pulmonary/systemic
blood flow ratio was calculated as pulmonary blood flow (in
The Journal of Thoracimilliliters per minute) divided by systemic blood flow (excluding
coronary flow, in milliliters per minute). CaO2 was calculated as
follows: Hemoglobin 1.36 SaO2)  0.0031 PaO2. Cere-
bral O2 delivery (in milliliter of O2 per milliliter) was calculated as
the product of CBF (in milliliters per minute per 100 g) and CaO2
(in milliliters of O2 per 100 mL). The arteriovenous O2 saturation
difference was calculated as the difference between arterial O2
saturation and jvSO2.
Statistical Analysis
All physiologic data are expressed as means  SEM. Normal
distribution of variables was assessed with the Kolmogorov-Smir-
nov normality test. Relations between rSO2 and other variables
were determined by means of least-squares regression analysis and
calculation of Pearson correlation coefficients. One-way repeated-
measures analysis of variance was used to compare physiologic
data obtained at different data points during the experiment (base-
line, 30 minutes, 120 minutes, and during afterload augmentation).
Results
Relevant physiologic data are summarized in Table 1. Tem-
perature and hemoglobin concentration remained un-
changed throughout the experiment. Dopamine administra-
tion was unchanged during the experiment (from 7.1  0.8
to 7.8  0.8, 6.5  0.8, and 6.0  0.8 g · kg1 · min1 at
baseline, 30 minutes, 120 minutes, and afterload augmen-
tation, respectively), as was epinephrine administration
(from 0.07  0.01 to 0.07  0.01, 0.06  0.01, and 0.06 
0.01 g · kg1 · min1 at various experimental data points).
Total left ventricular output increased significantly after
conversion to SVP. The pulmonary/systemic blood flow
ratio trended higher from 30 minutes to 120 minutes and
increased significantly during afterload increase. Creation
of SVP resulted in a significant decrease in diastolic arterial
pressure, rSO2, arterial O2 saturation, CaO2, and jvSO2 (P
 .05) and in a trend toward lower cerebral O2 delivery.
Afterload augmentation caused an increase in rSO2, arterial
O2 saturation, CaO2, and jvSO2 (P  .05), whereas cerebral
O2 delivery remained unaffected as a consequence of CBF
trending lower (Table 1).
Table 2 shows the Pearson correlation coefficient and
coefficient of determination (R and R2) for each variable
tested against the rSO2 index. A significant positive corre-
lation was noted between rSO2 and arterial O2 saturation,
jvSO2, CaO2, and jugular venous oxygen content (P 
.0001). A weak correlation was noted between rSO2 and
CBF (R  0.39, P  .05) and between rSO2 and cerebral
O2 delivery (R  0.29, P  .1), whereas the low coefficient
of determination (R2) suggested a lack of predictive value of
rSO2 for both variables.
Figures 1 through 5 illustrate the statistical relationship
between rSO2 and other physiologic variables. Linear rela-
tions were observed between rSO2 and arterial O2 saturation
(Figure 1), jvSO2 (Figure 2), and CaO2 (Figure 3). Con-
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4) and CBF (Figure 5).
Discussion
The primary focus of this investigation was to establish the
relationship between rSO2 and other physiologic indicators
of cerebral oxygenation under conditions of hypoxemia and
SVP. The main finding of this study is that in our acute
model of SVP, rSO2 correlated well with jvSO2 and paral-
leled changes in arterial oxygenation. On the basis of our
findings, a decrease in rSO2 can be expected when hypox-
emia and SVP are introduced acutely. However, our study
also shows that in this physiologic condition changes in
rSO2 might have a limited value in reflecting changes in the
adequacy of cerebral perfusion when simultaneous changes
in arterial O2 saturation are occurring.
Detection and prevention of cerebral hypoxia might be
critical to avoid adverse neurologic outcomes in children
with congenital heart disease.8 Cyanotic children with SVP
Table 1. Physiologic data at various experimental data po
Variable Baseline
rSO2 index 45  2
Temperature (°C) 36.1 0.2
Heart rate (beats/min) 160 15
Systolic arterial pressure (mm Hg) 113 4
Diastolic arterial pressure (mm Hg) 67 4
Mean arterial pressure (mm Hg) 84 4
Total LV outflow indexed (mL · kg1 · min1) 129 13
Qp/Qs NA
Arterial pH 7.40 0.0
pCO2 (mm Hg) 38  4
Arterial O2 saturation (%) 98  1
Hb (g/dL) 9.3 0.5
Arterial O2 content (mL O2/100 mL) 12.8 0.7
Jugular venous O2 saturation (%) 59  4
Cerebral blood flow (mL/min per 100 g) 63 5
Cerebral O2 delivery (mL O2/min per 100 g) 8.5  1
rSO2, Cerebral oxygen saturation; LV, left ventricular; Qp/Qs, pulmonary/sys
with baseline (1-way analysis of variance). †P  .05 compared with 30 min
analysis of variance).
Table 2. Correlation of physiologic variables with cerebra
Variable R
Arterial O2 saturation 0.8
Jugular venous O2 saturation 0.8
Arterial O2 content (mL O2/100 mL) 0.8
Jugular venous O2 content 0.7
Cerebral O2 delivery 0.2
A-V O2 saturation difference 0.0
Cerebral blood flow 0.3A-V O2, Arteriovenous O2 saturation difference.
398 The Journal of Thoracic and Cardiovascular Surgery ● Febrmight be especially vulnerable to cerebral hypoxia and brain
injury because they are hypoxemic and have a limited
cardiac output reserve.16 NIRS technology has recently
emerged as an effective and noninvasive tool to monitor
brain oxygenation perioperatively. Clinically, NIRS-based
brain monitoring with algorithms for interventions has been
proposed as a tool to reduce the incidence of postoperative
neurologic complications both in adult cardiac and congen-
ital cardiac surgery.
Oxygen transport to the brain is a complex phenomenon
influenced by several physiologic variables. These might
have an effect on rSO2 and on its ability to detect cerebral
hypoxia.17 Oxygen delivery to the brain is determined by
CBF and CaO2, which in turn is influenced by hemoglobin
concentration and arterial O2 saturation. NIRS has been
shown to monitor oxygen saturation in a selected region of
cerebral cortex.18 Previous work has demonstrated that
rSO2 parallels closely cerebral venous saturation because of
the overrepresentation of the venous capillary component
30 min 120 min Afterload
19  2* 25  2* 44  2†‡
35.1 0.2 36 0.3 35.9  0.3
181  7 195  5 199  5*
114  5 119  5 157  8*
47  3* 55  6 79  3†‡
69  4 79  6 108  4†‡
202  19* 226 15* 233  12*
0.97 0.1 1.44 0.1 1.73  0.1†
7.25 0.02* 7.28 0.04 7.31  0.03
47  3 47  4 33  4†‡
67  4* 74  2* 88  2†‡
9.4  0.3 10 0.3 10.1  0.2
8.5 0.3* 11 0.5 12.4  0.8†
33  2* 43  2 58  5†
77  8 61  12 46  5
6.4  0.6 6.3  1 6.8  0.8
blood flow ratio; NA, not applicable; Hb, hemoglobin. *P  .05 compared
(1-way analysis of variance). ‡P  .05 compared with 120 minutes (1-way
saturation
R2 P value
0.72 .0001
0.71 .0001
0.65 .0001
0.56 .0001
0.08 .1
0.007 .6
0.12 .05ints
3
temic
utesl O2
5
3
1
4
9
8
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Kurth and colleagues,18 as well as others,12,17 found a
significant correlation between cerebral saturation measured
by using NIRS technology and cerebral venous saturation.
In the setting of biventricular physiology and steady pul-
Figure 1. Correlation between cerebral O2 saturation (rSO2) and
arterial O2 saturation, with regression line and confidence-pre-
diction intervals.
Figure 2. Correlation between cerebral O2 saturation (rSO2) and
jugular venous O saturation (jvSO ), with regression line and2 2
confidence-prediction intervals.
The Journal of Thoracimonary function, arterial O2 saturation and CaO2 are un-
likely to change, at least over short periods of time. If
cerebral metabolism and oxygen consumption remain con-
stant during the same time interval, changes in cerebral
venous O2 saturation and therefore rSO2 can be assumed to
reflect changes in CBF and ultimately cerebral O2 delivery.
Figure 3. Correlation between cerebral O2 saturation (rSO2) and
arterial O2 content (CaO2), with regression line and confidence-
prediction intervals.
Figure 4. Correlation between cerebral O2 saturation (rSO2) and
cerebral O delivery, with regression line and confidence-predic-2
tion intervals.
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useful in clinical practice because it can provide information
on the adequacy of cerebral perfusion.3-5
In SVP, however, changes in arterial O2 saturation can
occur rapidly as a result of the varying balance between
systemic and pulmonary vascular resistance.19 These could
affect rSO2 and interfere with the ability of NIRS to reflect
changes in the relationship between cerebral O2 supply and
demand. As Table 1 shows, in our experimental model the
rSO2 index decreased in parallel with cerebral O2 delivery
and arterial O2 saturation as the SVP model was established.
However, this correlation was lost when afterload augmen-
tation was introduced because rSO2 increased significantly,
whereas cerebral O2 delivery did not. In our experiment
afterload augmentation caused a significant increase in ar-
terial pressure and pulmonary blood flow through the aor-
topulmonary shunt, which in turn resulted in higher arterial
O2 saturation and lower PCO2. These physiologic changes
caused a modest decrease in CBF. The net result of the
higher CaO2 and lower CBF was that cerebral O2 delivery
remained unaffected, whereas rSO2 increased significantly,
tracking the increasing arterial O2 saturation.
Continuous monitoring of rSO2 allows rapid recognition
of cerebral hypoxia20 and immediate feedback on the effi-
cacy of therapeutic maneuvers aimed at improving cerebral
oxygenation.3 The use of NIRS for brain monitoring has
been especially studied in the setting of cardiac operations.
Figure 5. Correlation between cerebral O2 saturation (rSO2) and
cerebral blood flow, with regression line and confidence-predic-
tion intervals.In 250 children undergoing operations for congenital heart
400 The Journal of Thoracic and Cardiovascular Surgery ● Febrdisease, Austin and coworkers8,9 found that using NIRS
brain monitoring to guide interventions to improve cerebral
oxygenation resulted in a decrease in the incidence of neu-
rologic sequelae and shorter hospital stay. Similarly, NIRS
has been proposed as a useful tool to monitor brain oxy-
genation both preoperatively10 and postoperativly,11 al-
though the experience in these settings is more limited. The
implications of our findings as they relate to rSO2 monitor-
ing in children with SVP could be significant in that they
unveil a physiologic situation in which the use of rSO2 as a
surrogate indicator of the adequacy of cerebral perfusion
might have limitations. The response to afterload augmen-
tation noted in our piglets suggests that NIRS data need to
be interpreted with caution if simultaneous changes in ar-
terial O2 saturation are occurring. These should be taken
into account when making assumptions on the efficacy of
therapeutic maneuvers in improving brain oxygenation.
Our findings must be interpreted in light of the limita-
tions inherent with the experimental model. Despite the fact
that this model has been validated previously, it is unknown
whether our experimental conditions reproduce cardiovas-
cular changes occurring in children with SVP. Differences
between animal species and human subjects could also
influence rSO2 monitoring with NIRS. Additional limita-
tions relate to the method used to increase afterload (ie,
balloon inflation in the descending thoracic aorta). We used
aortic occlusion because this method has been validated by
others21 and is highly reproducible. In addition, because our
piglets were already receiving inotropic support during the
entire experiment, further increasing afterload through ad-
ditional pharmacologic interventions would have been im-
practical. Nonetheless, we acknowledge that aortic occlu-
sion might have produced physiologic changes in the SVP
model that are not directly equivalent to those observed in
clinical practice when afterload is manipulated pharmaco-
logically. Also, the fact that afterload increases were pro-
duced 2 hours after creation of the model might have been
associated with some deterioration of the experimental
preparation.
In our study we did not measure intracranial pressure,
and therefore we cannot draw conclusions on the effect of
this variable on rSO2 changes. It is also possible that after-
load augmentation induced changes in the cerebral circula-
tion that affected the balance between arterial and venous
components as detected by the NIRS signal, therefore in-
fluencing rSO2 values. Additional weaknesses relate to the
lower hemoglobin concentration found in piglets, unlike the
relative polycythemia seen clinically, and to the use of
jugular venous saturation as opposed to sagittal sinus satu-
ration to estimate cerebral venous oxygenation.
Despite the many limitations, this study could provide
additional information on the use of NIRS in children with
univentricular physiology. NIRS technology is useful be-
uary 2006
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ETcause it allows the rapid and noninvasive detection of ce-
rebral hypoxia and the assessment of responses to therapeu-
tic maneuvers aimed at improving cerebral oxygenation.
Our study suggests that in the setting of SVP, rSO2 trends
need to be interpreted in the context of changes in arterial
O2 saturation. Our findings do not diminish the value of
transcranial NIRS in assessing cerebral oxygenation. How-
ever, they provide a useful adjunct to the interpretation of
rSO2 changes when simultaneous changes in arterial oxy-
genation are occurring.
We thank Somanetics Corporation, Troy, Mich, for providing
the NIRS equipment. We thank Dr Erle H. Austin for sharing with
us useful information on the SVP model. We are grateful to Dr
Kenneth G. Proctor for his invaluable support.
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Discussion
Dr Donald B. Doty (Salt Lake City, Utah). It seems to be a little
more directly associated but it is frontal blood supply. We would
like to know motor blood supply rather than frontal lobe, so there
are some limitations regarding the predictability of the technique
you used. Plus, you have set up a very complex model in which
you are trying to use the left ventricle as a single ventricle, totally
disabling the right ventricle and then supporting these animals with
multiple medications. Anybody who has ever done these kinds of
experiments with single ventricles, either right-side ventricle or
left-side ventricle, has found it extraordinarily difficult to sustain
and support this acute experiment. We give you a lot of credit for
being able to carry this through. Unfortunately, what we are left
with is this question: Does this NIRS really offer any advantage
over what we already have in terms of SVP where afterload and
the medications and so on are so strongly influencing what we
observe? I guess what the real question, after hearing all of this, is,
how does it apply clinically? Have you tried it in patients after a
Norwood procedure? Do you use it after palliation of a hypoplastic
right ventricle?
Dr Ricci. Thank you for your comments. I share your view on
the difficulty of the model. This model is not only difficult but also
very humbling and we certainly lost a lot of animals in trying to
refine it and get to this point.
Of course NIRS has been proposed and has been used with
increasing frequency at many centers including ours, because it
might provide some information on the balance between supply
and demand and, therefore, on the adequacy of cerebral oxygen-
ation. However, it has limitations. Our hypothesis was that, as
NIRS is essentially a very reliable indicator of cerebral venous
oxygenation, changes in arterial oxygenation could influence the
NIRS signal and could affect the ability of this technology in
providing information on cerebral oxygenation. Obviously after
we got into our conclusions, our impression is that in SVP, since
there is a possibility that the CaO2 might change in contrast to
normal biventricular physiology, simultaneous changes in arterial
saturation need to be taken into account when interpreting NIRS
changes.
As far as the extent to which these findings would apply and
change our management in clinical situations, I cannot answer that
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ETquestion. I can tell you that we are using this technology now in
our pediatric intensive care unit for all our pediatric patients,
including patients with SVP. We began using it relatively recently,
so I do not have clinical data to share with you regarding this.
However, knowing what we know now, let’s say we see that the
cerebral saturation by NIRS had declined by 20% in a child with
SVP. Based on this and other clinical indicators, we would insti-
tute therapeutic maneuvers to try to correct that, with the assump-
tion that cardiac output may be low. Then, we know that if we see
a rise in cerebral oxygenation as shown by NIRS in response to the
intervention, and that, for example, the NIRS increase corresponds
to a simultaneous rise in arterial oxygenation, then that NIRS rise
might not necessarily indicate better cardiac output in response to
the intervention. It could simply reflect improved arterial oxygen-
ation. I do not know whether the message is clear, but I think these
findings insert an additional element in the equation when making
clinical decisions based on NIRS, which I think is important.
Dr Doty. So the question is, does everybody who does this kind
of work need to run out and buy one of these things tomorrow, or
are you still content with getting along with what you had before,
which is nothing?
Dr Ricci. I don’t think I can answer that question based on
these data.
Dr John Meyer (Boston, Mass). It seems to me that the
longstanding problem with using this technology has been trying
to figure out what is happening to the blood that is in the pathway
402 The Journal of Thoracic and Cardiovascular Surgery ● Febrof your NIRS signal versus what is happening in the parenchyma.
What your information would indicate to me, or the way I would
interpret it, is that the NIRS technology is picking up what is
happening in the blood, not what is happening in the cerebral
parenchyma. The problem of trying to separate out those two
contributors to your NIRS data has been a difficult one. I think
actually this is pretty good information to suggest that the NIRS
signal may not be reflecting what is going on in the cerebral
parenchyma, the neuronal cells, and is probably more reacting to
or a function of what’s happening in the blood that happens to be
in the pathway between the signal. I think from that standpoint this
is actually an extremely useful study and I congratulate you on
doing it.
Dr Ricci. We used 0.25.
Unidentified Speaker. A number of years ago, in the days
when we were letting babies sit around waiting for a heart trans-
plant, a colleague of mine in Salt Lake City looked at carotid blood
flow but at lower oxygen saturation and it just drove home the
physiologic point. He found that the flow, and actually what he
calculated was a crude measure of oxygen delivery to the brain,
was better at a lower FIO2 than it was higher. I guess it just drives
home the point that oxygen delivery is ultimately determined by
hemoglobin, oxygen saturation, and flow. Once again we learned
the foundation of physiology here. Thank you.Dr Ricci. Thank you.
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